TwitterLinkedinSkypeRssEmail
+1.970.776.4355
BlueIron IP
  • About
  • IP-Backed Loans
  • Blog
  • Resources
    • MPEP (Annotated)
    • Patent Law FAQ
  • Contact
  • Schedule a Call

How does changing numeric range limits affect patent claim scope?

By russ.krajec@blueironip.com | September 29, 2024

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Changing numeric range limits can significantly affect patent claim scope.…

Read More

How does adding a specific limitation to a claim affect its scope?

By russ.krajec@blueironip.com | September 29, 2024

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Adding a specific limitation to a claim typically narrows its…

Read More

What is the significance of the original patent requirement in reissue applications?

By russ.krajec@blueironip.com | September 27, 2024

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The original patent requirement is a crucial aspect of reissue…

Read More

How does the Antares Pharma case impact the original patent requirement?

By russ.krajec@blueironip.com | September 27, 2024

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The Antares Pharma Inc., v. Medac Pharma Inc. case significantly…

Read More
« Newer Posts

Search

Categories

Recent Posts

  • CES and Grifting the Entrepreneurial Ecosystem
  • Stolen Valor: How Sleazy Patent Attorneys Abuse Inventorship
  • Four Horsemen of the Investor Apocalypse
  • AI-Assisted Patent Search Tools Exacerbate Inventor Biases
  • Your Patent Attorney Is NOT Giving Business Advice
  • Contempt from Crowdfunded Equity
  • Entrepreneurs and Imposter Syndrome
  • Blog
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Media Kit
BlueIron IP | 1635 Foxtrail Drive, Ste 321 | Loveland, Colorado 80538 | USA